Imatinib vs Ipilimumab

## Imatinib vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Imatinib** and **Ipilimumab**.

## Mechanism of Action

**Imatinib**: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Imatinib — 18 hours; Ipilimumab — 14.7 days.

## Chemical Properties

**Molecular Formula**: Imatinib — C29H31N7O; Ipilimumab — N/A.

**Molecular Weight**: Imatinib — 493.6030 g/mol; Ipilimumab — N/A.

**Type**: Imatinib — Small molecule; Ipilimumab — Antibody.